צמיחת מכירות ב-12 חודשים נגררים: Aptose Biosciences (APTO)

This chart of year-over-year revenue growth over the last 12 months illustrates the dynamics of Aptose Biosciences Inc. (APTO), where 0.00 serves as the base parameter value. Aptose Biosciences Inc. develops targeted therapies for hemoblastoses, leveraging inhibitor patents to ensure long-term profitability. These developments are based on the creation of next-generation small molecules, and the company is currently accelerating trials of oral agents to combat leukemia.
Aptose Biosciences (APTO) - פילוחי מדדים ודוחות פיננסיים

This indicator measures the percentage change in revenue over a rolling year, neutralizing seasonality by comparing the current twelve-month period with the equivalent prior period. By analyzing the relative year-over-year (LTM) revenue dynamics, an investor assesses the cash flow stability of Aptose Biosciences Inc. (APTO), which is critical when implementing joint clinical projects to develop kinase inhibitors in partnership with global biopharma behemoths.